e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Global tuberculosis control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Non-concordance of contacts with the Leicester TB contact screening programme: Evaluation of secondary disease risk
P. Haldar, G. Woltmann (Leicester, United Kingdom)
Source:
Annual Congress 2010 - Global tuberculosis control
Session:
Global tuberculosis control
Session type:
Thematic Poster Session
Number:
3156
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Haldar, G. Woltmann (Leicester, United Kingdom). Non-concordance of contacts with the Leicester TB contact screening programme: Evaluation of secondary disease risk. Eur Respir J 2010; 36: Suppl. 54, 3156
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Screening coverage and treatment loss to follow-up of Diabetes and Tuberculosis (TB) patients in hospitals with measures to integrate care of Diabetes and TB and those without integration measures in Malawi
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Increased incidence of TB disease within the health-care workers in an intermediate TB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Parameters influencing smoking cessation for asthma patients participating in a disease management program (DMP)
Source: Annual Congress 2013 –Smoking cessation
Year: 2013
Cohort analysis of a large community-based latent tuberculosis screening and treatment programme in a high incidence setting in East London
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Predicting risk of undiagnosed COPD in primary care: Development and validation of the TargetCOPD model
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Knowledge and attitude about tuberculosis disease in a health workers population
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate?
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Evaluation of adherence to tuberculosis screening in children
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Identification of new immigrants to the UK for latent tuberculosis screening: A comparison of employment and primary care registries
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Prevalence of depression in tuberculosis patients in comparison to non-tuberculous family contacts visiting the DOTS Clinic in tertiary care hospital and its correlation with disease pattern
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
Impact of social support programme on MDR-TB patients' treatment outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Accuracy of different screening strategies for undiagnosed COPD in primary care in China: a Breathe Well study
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021
Knowledge and attitudes of chest physicians regarding screening of household contacts of MDR TB patients & infection control.
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Tuberculosis and intravenous drug users, impact of proximity measures in screening and treatment
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Low real-world utility of IGRA when screening for LTBI in a low incidence setting
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept